Evidence map›Paper›PMID 30097610›Full record

ArticleScientific reports2018

On detection of periodicity in C-reactive protein (CRP) levels.

Mohsen Dorraki, Anahita Fouladzadeh, Stephen J Salamon, Andrew Allison, Brendon J Coventry, Derek Abbott

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The development of tumour vascular networks.Communications biology · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohsen DorrakiSchool of Electrical & Electronic Engineering, University of Adelaide, Adelaide, South Australia, 5005, Australia. mohsen.dorraki@adelaide.edu.au.ORCID 0000-0002-6675-3393
Anahita FouladzadehDepartment of Surgery & Tumour Immunotherapy Laboratory, University of Adelaide, Royal Adelaide Hospital, Adelaide, South Australia, 5005, Australia.
Stephen J SalamonSchool of Electrical & Electronic Engineering, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Andrew AllisonSchool of Electrical & Electronic Engineering, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Brendon J CoventryCentre for Biomedical Electrical Engineering (CBME), University of Adelaide, Adelaide, South Australia, 5005, Australia.
Derek AbbottSchool of Electrical & Electronic Engineering, University of Adelaide, Adelaide, South Australia, 5005, Australia.ORCID 0000-0002-0945-2674

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C-reactive protein (CRP) is an acute-phase plasma protein that can be used as a biomarker for activation of the immune system. A spectral analysis of CRP level over time for patients with gynaecological tumours has been reported by Madondo et al., using a periodogram method, suggesting that there is no significant periodicity in the data. In our study, we investigate the impact of low sample number on periodogram analysis, for non-uniform sampling intervals-we conclude that data of Madondo et al. cannot rule out periodic behaviour. The search for patterns (periodic or otherwise) in the CRP time-series is of interest for providing a cue for the optimal times at which cancer therapies are best administered. In this paper we show (i) there is no evidence to rule out periodicity in CRP levels, and (ii) we provide a prescription for the minimum data sample rate required in future experiments for improved testing of a periodic CRP signal hypothesis. The analysis we provide may be used for establishing periodicity in any short time-series signal that is observed without a priori information.

Indexed as

C-Reactive ProteinPeriodicityAlgorithmsBiological AssayBiomarkersHumansModels, TheoreticalTime FactorsBiomarkersC-Reactive Protein

Identifiers

PMID30097610
PMCPMC6086826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.